Clinical Trials Directory

Trials / Sponsors / ISU Abxis Co., Ltd.

ISU Abxis Co., Ltd.

Industry · 9 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
RecruitingEvaluate the Safety and Efficacy of Fabagal® (Agalsidase Beta) in Patients With Fabry Disease
Fabry Disease
Phase 32023-04-14
CompletedA Phase I Study to Compare Abcertin and EU-sourced Cerezyme® in Healthy Volunteers
Gaucher Disease
Phase 12020-01-29
UnknownStudy of ISU104, Targeting ERBB3 in Patients With Advanced Solid Tumors
Solid Tumor
Phase 12018-04-27
CompletedDose-escalation Study to Investigate the Safety, PK, and PD of ISU304/CB2679d in Hemophilia B Patients
Hemophilia B
Phase 12017-06-03
UnknownExploratory P2 Trial to Evaluate Efficacy and Safety of Clotinab® (Abciximab) in Acute MI Patients
Acute Myocardial Infarction
Phase 22013-05-01
CompletedPhase III Study of ISU302 in Patients With Type 1 Gaucher Disease
Gaucher Disease, Type 1
Phase 32011-09-01
CompletedA Switch-Over Study of the Safety and Efficacy of ISU302 in Patients With Type 1 Gaucher Disease
Gaucher Disease
—2011-05-01
WithdrawnThe Safety and Efficacy Study of ISU302 in Patient With Type I Gaucher Disease
Gaucher Disease
Phase 32011-01-01
CompletedA Study of the Tolerability, Safety, and Pharmacokinetics of ISU302 in Healthy Volunteers
Gaucher Disease
Phase 12010-10-01